iron isomaltoside 1000 (Monofer®)

DRUG4 trials

Sponsors

Pharmacosmos A/S, Yonsei University

Conditions

Complex Valvular Heart SurgeryIron Deficiency AnaemiaIron-deficiencyNon-anaemic Patients Undergoing Cardiac Surgery

Phase 3

A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof

CompletedNCT01563367

Pharmacosmos A/SNon-anaemic Patients Undergoing Cardiac Surgery

Start: 2012-01-31End: 2013-09-30Updated: 2014-04-29

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors

CompletedNCT01895231

Pharmacosmos A/SIron-deficiency

Start: 2013-06-30End: 2016-12-31Updated: 2018-03-15

IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose

CompletedNCT02130063

Pharmacosmos A/SIron Deficiency Anaemia

Start: 2014-05-31End: 2015-08-31Updated: 2018-09-27

Unknown Phase

Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical Trial

CompletedNCT02862665

Yonsei UniversityComplex Valvular Heart Surgery

Start: 2016-08-31End: 2020-05-07Updated: 2020-08-18

Related Papers

The effect of perioperative intravenously administered iron isomaltoside 1000 (Monofer®) on transfusion requirements for patients undergoing complex valvular heart surgery: study protocol for a randomized controlled trial.

2018-07-045 citations